787 EFFECTS OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF BRIVANIB IN A PHASE I, OPEN-LABEL, MULTIDOSE STUDY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND OTHER SOLID TUMORS

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 50; p. S288
Main Authors El-Khoueiry, A, Lenz, H.J, Posey, J, Wood, T, Fischer, B, Sankar, V, Shariq, S, Kollia, G, Masson, E, Walters, I
Format Journal Article
LanguageEnglish
Published Elsevier B.V 2009
Subjects
Gastroenterology and Hepatology
Online AccessGet full text

Cover

More Information
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(09)60789-3